Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 12/20 | 1.00 |
| ▸ | G6PD | P11413 | 5/20 | 1.00 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | PHOSPHO1 | Q8TCT1 | 11/20 | 0.80 |
| ▸ | PMM2 | O15305 | 7/20 | 0.80 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.62 |
| ▸ | MIF | P14174 | 4/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414630 | 1.00 | MPI (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL12230504 | 0.89 | MPI (0.80) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL12230503 | 0.85 | MPI (0.78) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL25293413 | 0.84 | MPI (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL29394760 | 0.84 | MPI (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL12230488 | 0.84 | MPI (0.73) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL8372604 | 0.82 | MPI (0.72) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL8371744 | 0.79 | MPI (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL2757850 | 0.77 | KAT2B (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 | |
| SCHEMBL12230486 | 0.74 | MPI (1.00) | MPIG6PDAPOBEC3GKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968436-B2 | NADPH oxidase proteins | UNIV GRENOBLE ALPES (FR) | 2021-04-06 | — | — | US | disclosed |
| US-20200181583-A1 | NADPH Oxidase Proteins | UNIV GRENOBLE ALPES (FR) | 2020-06-11 | — | — | US | disclosed |
| US-20170088826-A1 | NADPH Oxidase Proteins | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-03-30 | — | — | US | disclosed |
| US-20170088826-A1 | NADPH Oxidase Proteins | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-03-30 | — | — | US | disclosed |
| US-20110257233-A1 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110257233-A1 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110257233-A1 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2011-10-20 | — | — | US | disclosed |
| WO-2011116355-A2 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011116355-A2 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257233-A1 | BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE | MPI, PMM2, GPI | MPI 1/4885G6PD 13/4885APOBEC3G 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.